The leading Advanced Melanoma Companies such as OncoSec Medical, Immunocore, Sanofi, TILT Biotherapeutics, Novartis ...
Explore the world's top 10 largest stock exchanges by market cap data and see how these financial giants shape the world ...
It included two of the March portfolio’s top three holdings: European drugmakers GSK and Sanofi. Relatedly ... It also opened a small outpost in Shanghai in 2021—its first investment office ...
Contribute to aakesh123242/market-1 development by creating an account on GitHub.
Novartis opened 2024 with the top deal on this list—a pair of cardiovascular contracts with Chinese biotech Shanghai Argo Biopharmaceutical ... Novavax provided Sanofi with the sole license to its ...
A 50 mL dose of contrast agent (Omnipaque, 350 mg I/mL; GE Healthcare, Shanghai, China) was injected into the antecubital ... Nadroparin (Fraxiparine, Sanofi Winthrop Industry) was administered ...
Sanofi has removed (PDF) a clutch of programs from its clinical pipeline, scratching out entries for its late-phase BTK inhibitor and phase 1 prospects linked to the multibillion-dollar takeovers ...
Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L'Oréal, the first of multiple share buybacks the French drugmaker has planned for 2025. L'Oréal was selling 29,556,650 ...
Sanofi Consumer Healthcare India Limited informed the exchanges that it has approved a final dividend of ₹55 per equity share having a face value of ₹10 each for the financial year ending ...
While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden child could be emerging in the form of Beyfortus. During its first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results